Drug Discovery & Development

News on drug screening, clinical trials, companion diagnostics, immunotherapy, & personalized therapies in genetics, genomics, and molecular diagnostics.

Freenome Maintains CRC Early Detection Timeline as New Biomarker Discovery Studies Progress

Premium

The company is using newly raised funds to support a disseminated trial model, which it said will help it keep its plans to finish the study by the end of 2021.

Senate Republicans Propose $36B for HHS Coronavirus Testing, Drug Development

The funding package earmarks billions for the Public Health and Social Services Emergency Fund and Biomedical Advanced Research and Development Authority.

Merus, Caris Life Sciences Partner to ID NRG1 Fusion-Positive Cancer Patients for Clinical Trial

Caris will sequence DNA and RNA for certain cancer patients and potentially help Merus enroll cancer patients with NRG1 fusions in the Phase I/II eNRGy trial for zenocutuzumab.

FDA Approves Epizyme's Tazverik, Roche CDx for EZH2-Mutated Follicular Lymphoma Patients

The accelerated approval is based on results from two cohorts of a Phase II, single-arm trial in which EZH2-mutated patients had an overall response rate of 69 percent.

Adaptive Eyes NGS-Based Test for T Cell Response in COVID-19

Premium

The diagnostics firm is conducting a 1,000-person study to find T cell profiles associated with the immune response to COVID-19 and recovery from the disease.

Apr 15, 2020

Axovant, Invitae Launch Free Genetic Testing Program for Lysosomal Storage Diseases

Feb 20, 2020

FDA Releases List of Evidence-Based PGx Variants

Jan 13, 2020

Adaptive Biotechnologies, Genentech Partner on MRD Testing in Venetoclax Clinical Trial

Dec 04, 2019

PGDx Gets IDE For Tissue NGS Test in Merck Immunotherapy Trial

Nov 27, 2019

HalioDx, OSE Immunotherapeutics Collaborate on Immune Biomarkers for NSCLC Treatment

Nov 19, 2019

HalioDx, Kite Pharma Extend Biomarker Collaboration

Nov 18, 2019

Centogene to Provide Diagnostic Testing Services for PTC Therapeutics Gene Therapy Program

Nov 13, 2019

Interpace Diagnostics Reports 33 Percent Q3 Revenue Growth; Changes Name to Interpace Biosciences

Nov 07, 2019

Centogene Prices US IPO at $14 per Share

Oct 17, 2019

Centogene Files to Go Public in US

Oct 10, 2019

FDA Issues Final Guidance on IVD Reviews for Investigational Cancer Drug Trials

Oct 10, 2019

UTC Labs, Principals Agree to Pay $42.6M in PGx Testing Fraud Case

Aug 16, 2019

Xylonix, BioGemex Ink MOU to Develop Point-of-Care Cancer Immunotherapy-Response Diagnostic

Aug 13, 2019

Adaptive Biotechnologies Q2 Revenues Rise 91 Percent

Jul 24, 2019

Gray Foundation Awards $25M in Cancer Research Grants

Jun 24, 2019

SpeeDx, GSK Sign Test Supply, Development Deal

May 07, 2019

Adial Pharmaceuticals, Eurofins Scientific Partner on CDx for Alcohol Use Disorder Drug

Apr 24, 2019

Macrogen, Exosome Plus Ink MOU, Deal for Exosome Isolation Kits

Feb 27, 2019

Danaher Prices $2.76B Offering of Common, Preferred Stock

Sep 26, 2018

Menu